Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've started Mounjaro, noticed something different about how often — or how much — you're urinating, and you'd like a straight answer. Changes in urination on tirzepatide are reported by some people, and understanding why they happen (and when they matter) is worth doing properly. Mounjaro is a prescription-only medicine; a clinical prescriber decides whether it is suitable for you. Here's what the evidence and official guidance actually say.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who notice a change in urination frequency early on Mounjaro are experiencing something relatively mundane. When tirzepatide reduces appetite significantly, people often change what they eat and drink: more water, fewer calories, less alcohol, fewer high-sodium foods. All of those shifts can increase how often you urinate, at least while your body adjusts.
There's a common assumption that Mounjaro must be directly acting on the kidneys or bladder to cause this. That's usually not what's happening. GIP and GLP-1 receptors, which tirzepatide activates, are found in many tissues, including the kidneys, but the most frequent cause of increased trips to the bathroom in the early weeks is simply dietary and behavioural change running ahead of the medicine's direct effects.
If you're also drinking considerably more fluid (whether because your prescriber advised good hydration or because nausea makes plain water more appealing) increased urination follows naturally. For most people, it settles. If it doesn't, or if the frequency is disruptive, that's a conversation for your prescribing team. Our guide on frequent urination on Mounjaro looks at this pattern in more detail.
The side-effect picture that genuinely warrants concern runs the other way: not enough urination. Mounjaro commonly causes gastrointestinal effects (nausea, vomiting, diarrhoea, particularly after a dose increase) and in some people those can be severe enough to cause dehydration. When the body is significantly dehydrated, the kidneys compensate by producing less urine. Dark, concentrated urine, dizziness, a dry mouth, or not urinating much across a full day after a bout of vomiting or diarrhoea are signs you need fluid and possibly medical support.
The NHS tirzepatide medicines page lists dehydration as a complication of severe gastrointestinal side effects and advises people to seek urgent help if they experience them. This isn't a reason to fear the medicine (most people manage side effects without difficulty) but it is a reason to stay properly hydrated and not push through repeated vomiting without speaking to your prescribing team. Read more about how Mounjaro affects urine output and kidney health if you want the fuller picture.
For people using Mounjaro to manage type 2 diabetes alongside weight, the relationship between the medicine and urination has an additional layer. Elevated blood glucose causes the kidneys to excrete glucose in urine, dragging extra water with it, which is why frequent urination is a classic symptom of poorly controlled diabetes. As tirzepatide improves glucose control, that mechanism is reduced, and urination patterns can shift noticeably. Some people actually find they urinate less as control improves, which can itself feel unfamiliar.
Conversely, if blood glucose drops too low (less likely with tirzepatide alone than with some diabetes medicines, but worth knowing) fluid regulation changes again. If you're managing diabetes and notice urination changes that don't fit the patterns above, discuss them with your prescriber rather than adjusting anything yourself. For a broader look at the medicine, the tirzepatide overview on our site covers the full clinical picture. Information on starting treatment privately is on our how to access Mounjaro page, which also covers the clinical assessment process and cost context.
Pain or burning when you urinate, a feeling of urgency you can't control, urine that looks pink or red, or a persistent pressure in your lower abdomen are not effects anyone should attribute to Mounjaro and then wait out. These point towards a possible urinary tract infection, kidney issue, or another condition that needs clinical assessment in its own right.
The question of whether Mounjaro can cause urinary infections is one we cover separately, and the short answer is that the medicine is not considered a direct cause, but being on any medicine doesn't protect you from infections either. If you notice blood in your urine while taking Mounjaro, treat it as you would at any other time: get it checked, the same day if possible. The MHRA Yellow Card scheme allows you to report any suspected side effect directly; doing so helps regulators build a more complete picture of real-world experience with newer medicines.
If you'd like to speak to our team about any symptoms you're experiencing on treatment, our prescribers are available seven days a week for aftercare. You can also get in touch with us directly. For anyone weighing up whether treatment might be suitable for them, our free consultation is the right first step, a GPhC-registered prescriber, not an algorithm, reviews every application.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.